{"entity":{"type":"insider","cik":"0001256847","url":"/insider/0001256847","json_url":"/insider/0001256847.json","name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":73,"n_filings":19,"first":"2003-11-04","last":"2013-11-26","span_basis":"filed_date"},"name_variants":[{"name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","source":"filing","n_filings":19,"first_seen":"2003-11-04","last_seen":"2013-11-26"}],"transactions":[{"id":5018726,"accession":"0001179110-13-017125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-017125","line_url":"/filing/0001179110-13-017125","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP; SALZMAN ALAN E","owner_display_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":813185.0,"shares_display":"813,185","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":44725175.0,"total_display":"44,725,175.00","total_whole":"44,725,175","shares_owned_after":2240328.0,"shares_owned_after_display":"2,240,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-22","filed_date":"2013-11-26","scope":"insider","n_lines":2},{"id":5162506,"accession":"0001179110-13-016868","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-13-016868","line_url":"/filing/0001179110-13-016868","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178120.0,"shares_display":"178,120","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":9796600.0,"total_display":"9,796,600.00","total_whole":"9,796,600","shares_owned_after":2979514.0,"shares_owned_after_display":"2,979,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-21","filed_date":"2013-11-21","scope":"insider","n_lines":2},{"id":5162487,"accession":"0001179110-13-016868","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-016868","line_url":"/filing/0001179110-13-016868","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6424.0,"shares_display":"6,424","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":353320.0,"total_display":"353,320.00","total_whole":"353,320","shares_owned_after":3141425.0,"shares_owned_after_display":"3,141,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-21","scope":"insider","n_lines":2},{"id":5290029,"accession":"0001179110-13-016755","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-13-016755","line_url":"/filing/0001179110-13-016755","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48494.0,"shares_display":"48,494","price_per_share":55.67,"price_display":"55.67","price_state":"stated","total_value":2699660.98,"total_display":"2,699,660.98","total_whole":"2,699,661","shares_owned_after":3147264.0,"shares_owned_after_display":"3,147,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-19","scope":"insider","n_lines":2},{"id":5290021,"accession":"0001179110-13-016755","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-016755","line_url":"/filing/0001179110-13-016755","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153777.0,"shares_display":"153,777","price_per_share":55.61,"price_display":"55.61","price_state":"stated","total_value":8551538.97,"total_display":"8,551,538.97","total_whole":"8,551,539","shares_owned_after":3191345.0,"shares_owned_after_display":"3,191,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider","n_lines":2},{"id":4866755,"accession":"0001179110-13-013359","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-13-013359","line_url":"/filing/0001179110-13-013359","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC; VANTAGEPOINT VENTURE PARTNERS IV LP; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP; VANTAGEPOINT VENTURE PARTNERS IV Q LP","owner_display_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3014000.0,"shares_display":"3,014,000","price_per_share":40.45,"price_display":"40.45","price_state":"stated","total_value":121916300.0,"total_display":"121,916,300.00","total_whole":"121,916,300","shares_owned_after":3331128.0,"shares_owned_after_display":"3,331,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-19","filed_date":"2013-08-21","scope":"insider","n_lines":5},{"id":4469464,"accession":"0001179110-13-005387","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-13-005387","line_url":"/filing/0001179110-13-005387","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; VANTAGEPOINT VENTURE PARTNERS IV Q LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800000.0,"shares_display":"4,800,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":115200000.0,"total_display":"115,200,000.00","total_whole":"115,200,000","shares_owned_after":6049128.0,"shares_owned_after_display":"6,049,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-03-19","scope":"insider","n_lines":3},{"id":3510219,"accession":"0001179110-12-016172","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-12-016172","line_url":"/filing/0001179110-12-016172","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_display_name":"SALZMAN ALAN E","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":854512.0,"shares_display":"854,512","price_per_share":18.84,"price_display":"18.84","price_state":"stated","total_value":16099006.08,"total_display":"16,099,006.08","total_whole":"16,099,006","shares_owned_after":10397928.0,"shares_owned_after_display":"10,397,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-14","filed_date":"2012-11-16","scope":"insider","n_lines":3},{"id":2419027,"accession":"0001179110-12-015024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-12-015024","line_url":"/filing/0001179110-12-015024","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"WAGEWORKS, INC.","issuer_ticker":"WAGE","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4641636.0,"shares_display":"4,641,636","price_per_share":16.45,"price_display":"16.45","price_state":"stated","total_value":76354912.2,"total_display":"76,354,912.20","total_whole":"76,354,912","shares_owned_after":7988312.0,"shares_owned_after_display":"7,988,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-09","filed_date":"2012-10-09","scope":"insider","n_lines":3},{"id":8975118,"accession":"0001179110-11-009934","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-009934","line_url":"/filing/0001179110-11-009934","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE PARTNERS IV Q LP; SALZMAN ALAN E","owner_display_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":8.67,"price_display":"8.67","price_state":"stated","total_value":26877.0,"total_display":"26,877.00","total_whole":"26,877","shares_owned_after":4836202.0,"shares_owned_after_display":"4,836,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-16","filed_date":"2011-06-20","scope":"insider","n_lines":3},{"id":8838304,"accession":"0001179110-11-009714","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-11-009714","line_url":"/filing/0001179110-11-009714","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":699.0,"shares_display":"699","price_per_share":8.81,"price_display":"8.81","price_state":"stated","total_value":6158.19,"total_display":"6,158.19","total_whole":"6,158","shares_owned_after":4839011.0,"shares_owned_after_display":"4,839,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-14","filed_date":"2011-06-15","scope":"insider","n_lines":3},{"id":8838298,"accession":"0001179110-11-009714","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-009714","line_url":"/filing/0001179110-11-009714","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":8.8,"price_display":"8.80","price_state":"stated","total_value":11440.0,"total_display":"11,440.00","total_whole":"11,440","shares_owned_after":4839645.0,"shares_owned_after_display":"4,839,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-13","filed_date":"2011-06-15","scope":"insider","n_lines":3},{"id":9052848,"accession":"0001179110-11-008983","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-008983","line_url":"/filing/0001179110-11-008983","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV LP","owner_display_name":"VANTAGEPOINT VENTURE ASSOCIATES IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":8.6,"price_display":"8.60","price_state":"stated","total_value":41280.0,"total_display":"41,280.00","total_whole":"41,280","shares_owned_after":4840823.0,"shares_owned_after_display":"4,840,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-26","filed_date":"2011-05-31","scope":"insider","n_lines":3},{"id":8876428,"accession":"0001179110-11-008624","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-11-008624","line_url":"/filing/0001179110-11-008624","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32750.0,"shares_display":"32,750","price_per_share":8.67,"price_display":"8.67","price_state":"stated","total_value":283942.5,"total_display":"283,942.50","total_whole":"283,943","shares_owned_after":4845172.0,"shares_owned_after_display":"4,845,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-25","filed_date":"2011-05-25","scope":"insider","n_lines":3},{"id":8876423,"accession":"0001179110-11-008624","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-11-008624","line_url":"/filing/0001179110-11-008624","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52196.0,"shares_display":"52,196","price_per_share":8.42,"price_display":"8.42","price_state":"stated","total_value":439490.32,"total_display":"439,490.32","total_whole":"439,490","shares_owned_after":4874844.0,"shares_owned_after_display":"4,874,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-24","filed_date":"2011-05-25","scope":"insider","n_lines":3},{"id":8876417,"accession":"0001179110-11-008624","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-008624","line_url":"/filing/0001179110-11-008624","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE PARTNERS IV LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV Q LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26703.0,"shares_display":"26,703","price_per_share":8.18,"price_display":"8.18","price_state":"stated","total_value":218430.54,"total_display":"218,430.54","total_whole":"218,431","shares_owned_after":4922134.0,"shares_owned_after_display":"4,922,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-23","filed_date":"2011-05-25","scope":"insider","n_lines":3},{"id":8819459,"accession":"0001179110-11-008338","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-11-008338","line_url":"/filing/0001179110-11-008338","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV LP; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":8.03,"price_display":"8.03","price_state":"stated","total_value":1003750.0,"total_display":"1,003,750.00","total_whole":"1,003,750","shares_owned_after":4946327.0,"shares_owned_after_display":"4,946,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-19","filed_date":"2011-05-19","scope":"insider","n_lines":3},{"id":8819454,"accession":"0001179110-11-008338","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-008338","line_url":"/filing/0001179110-11-008338#line-3","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV LP; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12593.0,"shares_display":"12,593","price_per_share":8.29,"price_display":"8.29","price_state":"stated","total_value":104395.97,"total_display":"104,395.97","total_whole":"104,396","shares_owned_after":5059578.0,"shares_owned_after_display":"5,059,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-17","filed_date":"2011-05-19","scope":"insider"},{"id":8819452,"accession":"0001179110-11-008338","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-008338","line_url":"/filing/0001179110-11-008338#line-2","is_derivative":false,"issuer_cik":"0001098349","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001098349","owner_cik":null,"owner_name":"VANTAGEPOINT VENTURE PARTNERS IV LP; SALZMAN ALAN E; VANTAGEPOINT VENTURE PARTNERS IV Q LP; VANTAGEPOINT VENTURE ASSOCIATES IV LLC; VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP","owner_display_name":"VANTAGEPOINT VENTURE PARTNERS IV LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1261.0,"shares_display":"1,261","price_per_share":8.29,"price_display":"8.29","price_state":"stated","total_value":10453.69,"total_display":"10,453.69","total_whole":"10,454","shares_owned_after":506512.0,"shares_owned_after_display":"506,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-17","filed_date":"2011-05-19","scope":"insider"}],"collapsed":true,"next_cursor":"2011-05-17|8819452","ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001158863","name":"WAGEWORKS, INC.","url":"/issuer/0001158863","role":"Ten percent owner, Other","n_filings":7,"first_seen":"2012-10-09","last_seen":"2013-11-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001316175","name":"Anthera Pharmaceuticals Inc","url":"/issuer/0001316175","role":"Ten percent owner","n_filings":6,"first_seen":"2011-05-05","last_seen":"2011-06-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001311396","name":"Aviza Technology, Inc.","url":"/issuer/0001311396","role":"Ten percent owner","n_filings":1,"first_seen":"2006-04-26","last_seen":"2006-04-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001088244","name":"Intermix Media, Inc.","url":"/issuer/0001088244","role":"Ten percent owner","n_filings":5,"first_seen":"2003-11-04","last_seen":"2005-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001256847","retrieved_at":"2026-08-24T22:14:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}